Not available
Quote | Cytori Therapeutics Inc. (NASDAQ:CYTX)
Last: | $ |
---|---|
Change Percent: | -5.59% |
Open: | $0.2265 |
Close: | $0.2077 |
High: | $0.2265 |
Low: | $0.2043 |
Volume: | 444,060 |
Last Trade Date Time: | 07/26/2019 04:57:10 pm |
News | Cytori Therapeutics Inc. (NASDAQ:CYTX)
Citing the need for a new identity to coincide with its new direction, Cytori Therapeutics (NASDAQ: CYTX ) will change its name to Plus Therapeutics (PSTV). The change will take effect in several weeks. More news on: Cytori Therapeutics, Inc., Healthcare stocks news, Read more ...
AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and identity. Since the beginning of 2019, the company has successfully evaluated and transformed its pipeline to place a stronger e...
Message Board Posts | Cytori Therapeutics Inc. (NASDAQ:CYTX)
Subject | By | Source | When |
---|---|---|---|
The stock still trades? | Dougie1128 | investorshub | 12/20/2020 4:37:06 AM |
Buy $HALB going $1-$5 | amitgupta | investorshub | 10/23/2020 3:17:13 PM |
Will short again if goes 0.04 | amitgupta | investorshub | 10/21/2020 3:27:37 PM |
Covered 2.5 m shares | amitgupta | investorshub | 10/21/2020 2:30:23 PM |
$CTYX getting super close here boyos. News | Threeflight | investorshub | 08/07/2020 11:00:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Cytori Therapeutics Inc. Company Name:
CYTX Stock Symbol:
NASDAQ Market:
Cytori Therapeutics Inc. Website:
AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and identity. Since the beginning of 2019, the company has successfully evaluated and transformed its pipeline to place a stronger e...
SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its new company direction following two recent asset sales and highlight key anticipated milestones on July 15, 2019 at 4:30 PM Eastern Ti...
AUSTIN, Texas, July 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided an update on the development of its proprietary drug, ATI-1123, based on recently obtained feedback from the United States Food and Drug Administration (FDA). ATI-1123 is a substantially...